ABSTRACTS - World Psychiatric Association

More documents

Recommendations

Info

control group from the general population. All the subjects were evaluated using MINI, QVF (a questionnaire developed for the assessment of photosensitivity) and ERG. There was a significant difference (p
activation in the left amygdalar region and left IFG in the negative condition. The DCM showed a direct effect in left amygdala and right IFG in PD patients in both panic-anxiogenic and negative conditions; a direct effect in healthy controls was observed only in the negative condition and in the regions of left amygdala, right and left IFG. The modulatory effect was significant from the right and left IFG to the left amygdala in healthy controls and this effect was driven by the negative context input. In the patients with PD, a significant modulatory effect from the left amygdala to the right IFG driven by the specific panic-anxiogenic context was verified. These results may suggest that in patients with PD a prominent bottom-up process is involved in specific panic anxiogenic conditions thus representing a weak modulation of the frontal area. PO2.11. THE CARDIORESPIRATORY RESPONSE TO PHYSICAL EXERCISE IN PANIC DISORDER D. Caldirola, F.L. Lopes, C. Namia, C. Carminati, L. Bellodi, G. Perna Vita Salute San Raffaele University, Milan, Italy; Faculty of Psychology, University of L’Aquila, Italy; Faculty of Health, Medicine and Life Sciences, University of Maastricht, The Netherlands Patients with panic disorder (PD) are described as presenting a less efficient cardio-respiratory (CR) response to endurance tasks. The objectives of our study were to evaluate the physical fitness and the CR response during an exercise testing in PD, and also whether cognitive variables could influence those responses. Ten PD outpatients and 10 healthy matched controls underwent a submaximal exercise testing on a treadmill with constant speed (4 km/h) and a gradually increased workload until they reached a target heart rate (HR) (Karvonen’s formula). The subjective effort and anxiety levels were assessed during the test. The CR physiology was assessed through a breath-by-breath system. Patients achieved the target HR earlier than controls, exhibited higher HR than controls in the beginning of the testing, showed lower average within-subject SDs of HR than controls in the phases that follow the endurance testing, showed lower oxygen consumption than controls at the target HR and maintenance phases, reached the ventilatory threshold earlier than controls, had positive correlations between HR and respiratory frequency (in the phases preceding and during the endurance testing) and negative between HR and tidal volume (in the phases that follow the endurance testing). Patients also showed higher anxiety levels in all the phases of the exercise, but it significantly decreased over the exercise. These data may suggest a low cardiorespiratory fitness in the patients with PD, which might be due to an inability in the functioning of the homeostatic brain, thus leading to a low vagal tone and increased sympathetic reactivity. PO2.12. EMOTIONAL INTELLIGENCE AND ALEXITHYMIA IN PANIC DISORDER G. Borriello, R. Menotti, L. Bellodi, G. Perna Vita Salute San Raffaele University, Milan, Italy; Faculty of Psychology, University of L’Aquila, Italy; Faculty of Health, Medicine and Life Sciences, University of Maastricht, Maastricht, The Netherlands emotional deregulation, inducing anticipatory anxiety and phobic avoidance (AGO). The purposes of this research, conducted on 27 patients with PD and 28 healthy controls, were to compare EI and AL in PD with/without AGO and controls; to test if different levels of AGO are related to EI and/or to AL; and the relationship between EI and AL. Patients with PD have lower strategical EI (p
Page 1 and 2:
P World Psychiatry OFFICIAL JOURNAL
Page 3:
WORLD PSYCHIATRIC ASSOCIATION INTER
Page 6 and 7:
RS2. New advances in diffusion magn
Page 8 and 9:
SW8. Treatments for pregnant women
Page 10 and 11:
cologic treatment options are now a
Page 12 and 13:
elation to particular treatments an
Page 14 and 15:
chotherapy (TFP), an outgrowth of p
Page 16 and 17:
obtaining open employment. Secondar
Page 18 and 19:
tion of diagnosis-specific suicide
Page 20 and 21:
US7. ADVANCES IN THE MANAGEMENT OF
Page 22 and 23:
those following birth. Very little
Page 24 and 25:
Page 26 and 27:
US14.2. COMMON AND RARE GENETIC VAR
Page 28 and 29:
cause within 12 months was 63 (Kapl
Page 30 and 31:
Page 32 and 33:
sentations, and the onset of effica
Page 34 and 35:
US23.3. NEUROGENETIC MECHANISMS OF
Page 36 and 37:
and physical disorders meets proble
Page 38 and 39:
parent-child relationship. A ration
Page 40 and 41:
specifically, these studies have ei
Page 42 and 43:
RS3.5. USING ANTIDEPRESSANTS (PLUS
Page 44 and 45:
BOLD signal differences in prefront
Page 46 and 47:
affective states and to increase in
Page 48 and 49:
account for over fifty per cent of
Page 50 and 51:
sequencing of the pathway to care o
Page 52 and 53:
RS14.2. OBSESSIVE-COMPULSIVE DISORD
Page 54 and 55:
RS16. SUPPORTED EMPLOYMENT FOR PEOP
Page 56 and 57:
RS18. CURRENT STATE AND FUTURE PROS
Page 58 and 59:
RS20. BRAIN SYSTEMS AND PSYCHOSIS R
Page 60 and 61:
andomly recruited from the Montpell
Page 62 and 63:
model requires a conceptual shift f
Page 64 and 65:
familiar with psychological vulnera
Page 66 and 67:
RS26.5. IMPLICATIONS OF RECOVERY: A
Page 68 and 69:
cotherapy, remain unclear. These ar
Page 70 and 71:
RS30.2. COMBINATION THERAPIES FOR P
Page 72 and 73:
RS32.2. CHRONOTHERAPEUTICS TO TREAT
Page 74 and 75:
RS34. THE EFFECTS OF PSYCHIATRIC CO
Page 76 and 77:
teristics than an African American
Page 78 and 79:
WO6. MANAGEMENT OF MENTALLY DISORDE
Page 80 and 81:
WO14. PRACTICAL ISSUES IN THE LONG-
Page 82 and 83:
espectively; for women with any psy
Page 84 and 85:
SS3. THE ASSOCIATION BETWEEN IMPULS
Page 86 and 87:
and blood samples were used for tol
Page 88 and 89:
(the need to avoid harm to a patien
Page 90 and 91:
SS9. IMPLEMENTING MENTAL HEALTH CAR
Page 92 and 93:
SS11. RECOVERY BEYOND RHETORIC (org
Page 94 and 95:
Romanian admission to the European
Page 96 and 97:
SS14.2. SUBJECT-SPECIFIC EEG ANALYS
Page 98 and 99:
SS16. HOPE IN PSYCHIATRY (organized
Page 100 and 101:
SS18. TOWARDS A CONSENSUS ON ETHICS
Page 102 and 103:
duced drugs that were marketed as a
Page 104 and 105:
treated for unipolar and bipolar de
Page 106 and 107:
long-term individual therapy, the t
Page 108 and 109:
provide a defence or to accept a de
Page 110 and 111:
SS28.2. DOCTORS’ HEALTH AND ADDIC
Page 112 and 113:
SS30.3. EVIDENCE-BASED PSYCHOTHERAP
Page 114 and 115:
has created a unique challenge for
Page 116 and 117:
SS35. ACCESS TO MENTAL HEALTH CARE:
Page 118 and 119:
SS36.3. BEHAVIOURAL AND COGNITIVE-B
Page 120 and 121:
SS38.2. DEPRESSION AND DEMENTIA: LE
Page 122 and 123:
need to show what it is doing to ad
Page 124 and 125:
the individual’s personhood (in e
Page 126 and 127:
taken into account and mood disorde
Page 128 and 129:
and psychiatric services at all lev
Page 130 and 131:
chose the field of psychoneuroimmun
Page 132 and 133:
ices to families (particularly chil
Page 134 and 135:
suffer from comorbid depression. In
Page 136 and 137:
American countries, that the majori
Page 138 and 139:
ZS10.5. STIGMA IN UKRAINE AND POST-
Page 140 and 141:
chotherapeutic schools, such as the
Page 142 and 143:
NRS2. GENETICS AND MOLECULAR BIOLOG
Page 144 and 145:
NRS3.2. EARLY DETECTION AND INTERVE
Page 146 and 147:
NRS4.4. DEPRESSIVE PERSONALITY AND
Page 148 and 149:
patients were enrolled; 38 were ran
Page 150 and 151:
NRS7.2. THE USE OF THE MOOD DISORDE
Page 152 and 153:
What were the missed opportunities
Page 154 and 155:
compared with those without rapid c
Page 156 and 157:
and poor control of impulsivity. Th
Page 158 and 159:
tainty, which, in turn makes it pos
Page 160 and 161:
they “did not want anyone to know
Page 162 and 163:
the SOHO studies and followed up to
Page 164 and 165:
occurring in the brain during REM s
Page 166 and 167:
(28.6%/44.0%), and after 12 months
Page 168 and 169:
adverse events (AEs). Eighty-one pa
Page 170 and 171: and worse global functioning (as ev
Page 172 and 173: ment response is defined primarily
Page 174 and 175: domized to treatment with either us
Page 176 and 177: PO1.56. RISPERIDONE AND HYPERPROLAC
Page 178 and 179: understanding and self-awareness (4
Page 180 and 181: five healthy subjects, genotyped fo
Page 182 and 183: patients and their relatives, the a
Page 184 and 185: PO1.86. VALACYCLOVIR-ASSOCIATED PSY
Page 186 and 187: effects of prenatal selective serot
Page 188 and 189: of these recovered patients, 10% re
Page 190 and 191: assess functional impairment. The F
Page 192 and 193: to recurrence of any mood event was
Page 194 and 195: demonstrated that declined group ha
Page 196 and 197: PO1.130. ARIPIPRAZOLE IN ACUTE MANI
Page 198 and 199: in maintenance therapy could be the
Page 200 and 201: PO1.145. BIPOLAR DISORDER WITH A DE
Page 202 and 203: the Consort Statement guidelines. R
Page 204 and 205: for evaluation and a diagnosis of t
Page 206 and 207: PO1.170. EVALUATION OF LIOTHYRONINE
Page 208 and 209: only up to primary level education
Page 210 and 211: sistencies among magnetic resonance
Page 212 and 213: suppression of the immune system in
Page 214 and 215: isk factor unique to this populatio
Page 216 and 217: went functional magnetic resonance
Page 218 and 219: study we generated the stable MES23
Page 222 and 223: PO2.14. AUGMENTATION WITH COGNITIVE
Page 224 and 225: PO2.22. FREQUENCY AND CLINICAL CORR
Page 226 and 227: CI -0.75; -0.14, p=0.004). In addit
Page 228 and 229: PO2.38. SPECTRUM OF SOCIAL ANXIETY
Page 230 and 231: PO2.46. CLINICAL HETEROGENEITY OF O
Page 232 and 233: studies are needed in order to iden
Page 234 and 235: alexithymia was observed in IBD, bu
Page 236 and 237: three time points (baseline, 12 and
Page 238 and 239: PO2.80. PERCEIVED FAMILY CONFLICTS
Page 240 and 241: PO2.88. BODY IMAGE IN A CLINICAL SA
Page 242 and 243: tions of self and others. These fea
Page 244 and 245: and socioeconomic status, we constr
Page 246 and 247: incipient during late adolescence a
Page 248 and 249: PO2.120. DEMOGRAPHIC AND CLINICAL F
Page 250 and 251: jective scale, there was significan
Page 252 and 253: PO2.137. SURVEY OF AN ALCOHOL SUPPO
Page 254 and 255: PO2.145. PATHOLOGICAL GAMBLING IN P
Page 256 and 257: eceptor subtypes. To understand bet
Page 258 and 259: PO2.160. TYPOLOGY OF BEHAVIOR PROFI
Page 260 and 261: ADHD and 25 healthy controls were a
Page 262 and 263: PO3.10. METHYLPHENIDATE TRANSDERMAL
Page 264 and 265: aripiprazole (15 mg/die), with dram
Page 266 and 267: PO3.26.2 IMPROVEMENTS IN MENTAL HEA
Page 268 and 269: health care settings to better meet
Page 270 and 271:
children with or without MDD, and t
Page 272 and 273:
shoulder pain unresponsive to non-s
Page 274 and 275:
PO3.58. EFFICACY OF LAMOTRIGINE IN
Page 276 and 277:
(mean 25.4-point change) and vitali
Page 278 and 279:
PO3.74. PSYCHIATRIC COMORBIDITY IN
Page 280 and 281:
in whom this type of intervention m
Page 282 and 283:
PO3.91. EFFECTIVENESS OF PSYCHOEDUC
Page 284 and 285:
ment choices. A 13-item questionnai
Page 286 and 287:
onset of depression, patients with
Page 288 and 289:
did not, also had poorer mental hea
Page 290 and 291:
lized a comparison group, and exami
Page 292 and 293:
PO3.133. PATTERNS OF CARE IN PATIEN
Page 294 and 295:
PO3.140. DRUG NON-COMPLIANCE: THE I
Page 296 and 297:
who were living part or full time w
Page 298 and 299:
developed by a task force appointed
Page 300 and 301:
lyzed using a modified grounded the
Page 302 and 303:
PO3.174. THE EMILIA PROJECT: THE ST
Page 304 and 305:
ecovered better from depression tha
Page 306 and 307:
students of the Islamic Azad Univer
Page 308 and 309:
individualized treatment plan, taki
Page 310 and 311:
side effects), and reaching an effe
Page 312 and 313:
models of circadian disturbances. M
Page 314 and 315:
tinuous antipsychotic protection. T
Page 316 and 317:
SPS9.5. IMPROVING CARDIOVASCULAR HE
Page 318 and 319:
although preliminary, are promising
Page 321 and 322:
INDEX OF AUTHORS Abbate A. 270 Abde
Page 323 and 324:
Benítez-Hernández M.M. 297 Benito
Page 325 and 326:
Centanaro F. 164 Cercignani M. 32 C
Page 327 and 328:
Diez T. 164 Dimitrijevic I. 244 Din
Page 329 and 330:
Gates D. 280 Gaviria S.L. 73 Gelao
Page 331 and 332:
Hua-Min Xu 210 Huang H. 247 Huang J
Page 333 and 334:
Kundi P.S. 257 Kunugi H. 248 Kupfer
Page 335 and 336:
Marder S.R. 103 Margari F. 274, 275
Page 337 and 338:
Napo F. 175 Narayana P.A. 76 Nardi
Page 339 and 340:
Pieper S. 31 Pierantozzi E. 193 Pie
Page 341 and 342:
Rybakowski J. 171 Ryder A.G. 138 Ry
Page 343 and 344:
Stoduto G. 280 Stone M.H. 5, 38 Sto
Page 345 and 346:
Villaseñor Bayardo S. 118 Vinberg
Page 347:
© 2009 by WPA Printed in Italy by
show all

ABSTRACTS - World Psychiatric Association

Create successful ePaper yourself

Delete template?

Save as template?